Effects of manufacturing procedures and preparation conditions on European Union priority polycyclic aromatic hydrocarbons in Oolong tea samples.


Journal

Food chemistry
ISSN: 1873-7072
Titre abrégé: Food Chem
Pays: England
ID NLM: 7702639

Informations de publication

Date de publication:
01 Oct 2021
Historique:
received: 28 12 2020
revised: 30 03 2021
accepted: 31 03 2021
pubmed: 3 5 2021
medline: 8 6 2021
entrez: 2 5 2021
Statut: ppublish

Résumé

The study evaluated the changes in polycyclic aromatic hydrocarbons (PAHs) of Oolong tea samples at each heat treatment stage of the manufacturing process, different post-treatment methods and different brewing conditions. The content of PAHs in the tea leaves was significantly increased during stir fixation (280 °C for 8 min) stage of the manufacturing process. In the subsequent heat treatment process, the PAHs content did not change much until the Oolong tea product (primary) was further roasted. The level of PAHs increased with the roasting time. Charcoal roasting resulted in higher PAHs content in the product compared with electric roasting. Higher brewing temperature caused higher level of PAHs released into the tea infusion. The level of released PAHs decreased with the increase of the number of tea brewing (the total released PAHs was about 4%). The risk assessment results for PAHs in the tea infusions showed a low level of health concern.

Identifiants

pubmed: 33933958
pii: S0308-8146(21)00891-8
doi: 10.1016/j.foodchem.2021.129885
pii:
doi:

Substances chimiques

Polycyclic Aromatic Hydrocarbons 0
Tea 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

129885

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Shih-Min Chiang (SM)

Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, ROC.

Kwo-Chang Ueng (KC)

Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, ROC; School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, ROC; Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan, ROC; Department of Internal Medicine, Division of Cardiology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan, ROC.

Hsiang-Shun Chen (HS)

Department of Health Food, Chung-Chou University of Science and Technology, 6, Lane 2, Sec. 3, Shanjiao Rd., Yuanlin City, Changhua County 510, Taiwan, ROC.

Chia-Jung Wu (CJ)

Institute of Food Safety and Health Risk Assessment, National Yang Ming Chiao Tung University, 155, Sec.2, Linong Street, Taipei 11221, Taiwan, ROC.

Yi-Sun Yang (YS)

Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, ROC; School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, ROC; Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan, ROC; Department of Internal Medicine, Division of Endocrinology and Metabolism, Chung Shan Medical University Hospital, 40201, Taiwan, ROC.

Deng-Jye Yang (DJ)

Institute of Food Safety and Health Risk Assessment, National Yang Ming Chiao Tung University, 155, Sec.2, Linong Street, Taipei 11221, Taiwan, ROC; Department of Nutrition and Master Program of Food and Drug Safety, China Medical University, 91, Hsueh-Shih Road, Taichung 40402, Taiwan, ROC; Department of Food Nutrition and Health Biotechnology, Asia University, 500, Lioufeng Rd., Wufeng, Taichung 41354, Taiwan, ROC. Electronic address: djyang1@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH